Roche (RHHBY) and Novartis (NVS) tout their U.S. investments as President Donald Trump imposes new 100% pharma tariffs. Read ...

Eli Lilly said on Thursday the U.S. Food and Drug Administration has approved its treatment for a form of advanced breast ...

Trump’s threat of a 100% tariff on imported branded or patented drugs sounds dramatic, yet, pharma stocks were mostly in the ...

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 3.1% in the afternoon session after the company halted a ...

I N recent months makers of weight-loss drugs have gone on a crash diet. In late July Novo Nordisk, the Danish firm that gave ...

Eli Lilly (LLY) remains a strong growth company, driven by leadership in the booming GLP-1 and diabetes drug markets despite ...

If you have been keeping an eye on Eli Lilly’s stock, you are not alone, and you are probably wondering if now is the right ...

Eli Lilly will make its next-generation experimental weight-loss pill, orforglipron, at a new multi-billion-dollar ...

Indianapolis-based Eli Lilly intends to build a biomanufacturing facility that would cost $6.5 billion to build and employ ...

Celltrion Inc. said in a regulatory filing in South Korea on Tuesday its U.S. subsidiary has acquired Imclone Systems LLC ...

South Korean biopharmaceutical company Celltrion said it would invest at least $1 billion to acquire a plant from Eli Lilly ...

Eli Lilly and Company (NYSE: LLY) is one of the 10 Best AI Stocks to Buy According to Goldman Sachs. On September 18, Wells ...